Genpharmasec Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
For the full year, sales was INR 255.16 million compared to INR 273.21 million a year ago. Revenue was INR 256.16 million compared to INR 274.13 million a year ago. Net income was INR 11.25 million compared to net loss of INR 2.09 million a year ago. Basic earnings per share from continuing operations was INR 0.04 compared to basic loss per share from continuing operations of INR 0.01 a year ago. Diluted earnings per share from continuing operations was INR 0.04 compared to diluted loss per share from continuing operations of INR 0.01 a year ago.